EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

4-Methylumbelliferone Modulates CAIX to Mitigate Hypoxia-Driven Dysregulation and Enhance PD-1 Immunotherapy in Lung Cancer

Mariel Fusco iD, Carlos Rafael Picón iD, Marco Aurelio Diaz iD, Juan Bayo iD, Paula Constanza Arriola Benitez, Flavia Piccioni iD, Noelia Gómez, Mara Stinco, Javier Martínez Martinez iD, José Nicolás Minatta, Ricardo Amorín iD, Martina Villar und 6 weitere

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms262110427 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Mariel Fusco und 17 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Immunobiology Laboratory, Facultad de Ciencias Biomédicas, Instituto de Investigaciones en Medicina Traslacional (IIMT), CONICET-Universidad A…. Hauptthemen laut MEDLINE: Carbonic Anhydrase IX, Lung Neoplasms, Programmed Cell Death 1 Receptor, Immunotherapy. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Consejo Nacional de Investigaciones Científicas y Técnicas, Austral University, Fundacion Florencio Fiorini.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hypoxia is a hallmark of solid tumors, driving metabolic reprogramming and immune evasion. In lung cancer, hypoxia-induced activation of carbonic anhydrase IX (CAIX) promotes lactate accumulation and extracellular acidification, fostering an immunosuppressive tumor microenvironment (TME). Analysis of public datasets revealed that patients with high CAIX expression exhibited significantly reduced median survival (p < 0.001). Moreover, CAIX correlated with HIF-1α, PD-L1, and immunosuppressant molecules, linking hypoxia-driven metabolic alterations with immune dysfunction. Here, we evaluated the capacity of 4-methylumbelliferone (4Mu) to counteract these effects and enhance antitumor immunity. In vitro, hypoxia increased CAIX and monocarboxylate transporter -4 (MCT4) expression in lung carcinoma cells, elevated lactate release, and reduced extracellular pH while promoting an M2-like macrophage profile and impairing antigen-specific splenocyte proliferation (p < 0.01). Treatment with 4Mu downregulated CAIX expression, restored extracellular pH, decreased lactate secretion, and rescued lymphocyte proliferation (p < 0.01). In vivo, 4Mu reduced CAIX expression, shifted macrophage polarization toward a pro-inflammatory phenotype, and enhanced CD8+ T cell infiltration. 4Mu was safe and well tolerated, and notably, combined with anti-PD-1 therapy, it synergistically inhibited tumor growth and increased both CD4+ and CD8+ T cell infiltration. These findings support 4Mu as a metabolic modulator capable of mitigating CAIX-driven acidosis and improving the efficacy of immunotherapy in lung cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carbonic Anhydrase IXLung NeoplasmsProgrammed Cell Death 1 ReceptorImmunotherapyHumansAnimalsTumor MicroenvironmentMiceCell Line, TumorFemaleGene Expression Regulation, NeoplasticAntigens, Neoplasm

Stichwörter der Autor:innen

4-methylumbelliferone (4Mu)carbonic anhydrase IX (CAIX)hypoxiatumor microenvironment

Substanzen

Carbonic Anhydrase IXProgrammed Cell Death 1 ReceptorCA9 protein, humanPDCD1 protein, humanAntigens, Neoplasm

Autor:innen und Institutionen

  • Cancer Immunobiology Laboratory, Facultad de Ciencias Biomédicas, Instituto de Investigaciones en Medicina Traslacional (IIMT), CONICET-Universidad Austral, Av. Presidente Perón 1500 Derqui-Pilar, Buenos Aires B1629ODT,…
  • Department of Clinical Oncology, Hospital Universitario Austral, Av. Presidente Perón 1500 Pilar, Buenos Aires B1629AJH, Argentina.
  • Programa de Hepatología Experimental y Terapia Génica, Facultad de Ciencias Biomédicas, Instituto de Investigaciones en Medicina Traslacional (IIMT), CONICET-Universidad Austral, Av. Presidente Perón 1500 Pilar, Buenos…
  • Facultad de Ingeniería, LIDTUA-CIC, Universidad Austral, Mariano Acosta 1611 Pilar, Buenos Aires B1629WWA, Argentina.
  • Grupo de Investigaciones Básicas y Aplicadas en Inmunología y Bioactivos (GIBAIB), Instituto de Ecología y Desarrollo Sustentable (INEDES), CONICET-Universidad Nacional de Luján, Luján B6700, Argentina.
  • Departamento de Ciencias Básicas, Universidad Nacional de Luján, Luján B6700, Argentina.

ORCID-Profile: Mariel Fusco, Carlos Rafael Picón, Marco Aurelio Diaz, Juan Bayo, Flavia Piccioni, Javier Martínez Martinez, Ricardo Amorín, Ignacio Cassol, Mauricio De Marzi, Manglio Miguel Rizzo, María Florencia Mercogliano, Mariana Malvicini

Förderung

  • Consejo Nacional de Investigaciones Científicas y Técnicas
  • Austral University
  • Fundacion Florencio Fiorini
  • CONICET
  • Concurso Interno de proyectos de Investigación Científica de la Universidad Austral
  • Fundación Florencio Fiorini

Zitieren

APA

Fusco, M., Picón, C. R., Diaz, M. A., Bayo, J., Arriola Benitez, P. C., Piccioni, F., Gómez, N., Stinco, M., Martínez Martinez, J., Minatta, J. N., Amorín, R., Villar, M., Sole, V., Cassol, I., De Marzi, M., Rizzo, M. M., Mercogliano, M. F., & Malvicini, M. (2025). 4-Methylumbelliferone Modulates CAIX to Mitigate Hypoxia-Driven Dysregulation and Enhance PD-1 Immunotherapy in Lung Cancer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262110427

Vancouver

Fusco M, Picón CR, Diaz MA, Bayo J, Arriola Benitez PC, Piccioni F, et al. 4-Methylumbelliferone Modulates CAIX to Mitigate Hypoxia-Driven Dysregulation and Enhance PD-1 Immunotherapy in Lung Cancer. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262110427

BibTeX
@article{Fusco2025,
  author = {Fusco, Mariel and Picón, Carlos Rafael and Diaz, Marco Aurelio and Bayo, Juan and Arriola Benitez, Paula Constanza and Piccioni, Flavia and Gómez, Noelia and Stinco, Mara and Martínez Martinez, Javier and Minatta, José Nicolás and Amorín, Ricardo and Villar, Martina and Sole, Valentina and Cassol, Ignacio and De Marzi, Mauricio and Rizzo, Manglio Miguel and Mercogliano, María Florencia and Malvicini, Mariana},
  title = {4-Methylumbelliferone Modulates CAIX to Mitigate Hypoxia-Driven Dysregulation and Enhance PD-1 Immunotherapy in Lung Cancer},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms262110427}
}
Kostenlos starten →